Cargando…

Dopaminergic therapy affects learning and impulsivity in Parkinson’s disease

OBJECTIVE: The aim was to examine the effect of dopaminergic medication on stimulus-response learning versus performing decisions based on learning. METHOD: To see the effect of dopaminergic therapy on stimulus-response learning and response selection, participants with Parkinson’s disease (PD) were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiebert, Nole M, Seergobin, Ken N, Vo, Andrew, Ganjavi, Hooman, MacDonald, Penny A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241810/ https://www.ncbi.nlm.nih.gov/pubmed/25493274 http://dx.doi.org/10.1002/acn3.128

Ejemplares similares

Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson's disease
por: Vo, Andrew, et al.
Publicado: (2014)

Striatum-Mediated Deficits in Stimulus-Response Learning and Decision-Making in OCD
por: Hiebert, Nole M., et al.
Publicado: (2020)

Biomarkers of Parkinson's disease: Striatal sub-regional structural morphometry and diffusion MRI
por: Khan, Ali R., et al.
Publicado: (2018)

Differential Effects of Parkinson's Disease and Dopamine Replacement on Memory Encoding and Retrieval
por: MacDonald, Alex A., et al.
Publicado: (2013)

Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson’s Disease
por: Yang, Xue Q., et al.
Publicado: (2018)

Examining dorsal striatum in cognitive effort using Parkinson's disease and fMRI
por: MacDonald, Alex A, et al.
Publicado: (2014)

Dopaminergic therapy affects learning and impulsivity in Parkinson’s disease
Publicado: (2014)

Relationship between Freezing of Gait and Anxiety in Parkinson's Disease Patients: A Systemic Literature Review
por: Witt, Ivan, et al.
Publicado: (2019)

SLC6A3 Polymorphism Predisposes to Dopamine Overdose in Parkinson's Disease
por: Robertson, Brian D., et al.
Publicado: (2018)

Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults
por: Gallant, Haley, et al.
Publicado: (2016)

Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers
por: Yang, Xue Qing, et al.
Publicado: (2016)

Differential Effects of Dopaminergic Therapies on Dorsal and Ventral Striatum in Parkinson's Disease: Implications for Cognitive Function
por: MacDonald, Penny A., et al.
Publicado: (2011)

Burning pain secondary to clozapine use: a case report
por: Linton, Bradley, et al.
Publicado: (2014)

Automatic Online Motor Control Is Intact in Parkinson’s Disease With and Without Perceptual Awareness
por: Merritt, Kate E., et al.
Publicado: (2017)

Network mechanisms of intentional learning
por: Hampshire, Adam, et al.
Publicado: (2016)

Subregional analysis of striatum iron in Parkinson’s disease and rapid eye movement sleep behaviour disorder
por: Alushaj, Erind, et al.
Publicado: (2023)

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s Disease
por: Erga, Aleksander H., et al.
Publicado: (2018)

Nigrostriatal Dopaminergic Denervation Does Not Promote Impulsive Choice in the Rat: Implication for Impulse Control Disorders in Parkinson’s Disease
por: Magnard, Robin, et al.
Publicado: (2018)

Negative Associations between Corpus Callosum Midsagittal Area and IQ in a Representative Sample of Healthy Children and Adolescents
por: Ganjavi, Hooman, et al.
Publicado: (2011)

Genetic Markers as Risk Factors for the Development of Impulsive-Compulsive Behaviors in Patients with Parkinson’s Disease Receiving Dopaminergic Therapy
por: Fedosova, Anna, et al.
Publicado: (2021)

Serotonergic and dopaminergic control of impulsivity in gambling disorder
por: Kaasinen, Valtteri, et al.
Publicado: (2023)

Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease
por: Hall, Alison, et al.
Publicado: (2021)

Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson’s disease
por: Weickert, Thomas W., et al.
Publicado: (2013)

Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome
por: Voon, Valerie, et al.
Publicado: (2011)

Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment
por: Canário, Nádia, et al.
Publicado: (2019)

An Exploration of Apathy and Impulsivity in Parkinson Disease
por: Ahearn, David J., et al.
Publicado: (2012)

Performance on the balloon analogue risk task and anticipatory response inhibition task is associated with severity of impulse control behaviours in people with Parkinson’s disease
por: Hall, Alison, et al.
Publicado: (2023)

Cognitive Training in Parkinson's Disease: A Review of Studies from 2000 to 2014
por: Glizer, Daniel, et al.
Publicado: (2016)

Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies
por: Martini, Alice, et al.
Publicado: (2018)

Impulsivity in Parkinson’s Disease Is Associated With Alterations in Affective and Sensorimotor Striatal Networks
por: Ruitenberg, Marit F. L., et al.
Publicado: (2018)

Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
por: Lee, Myung Jun, et al.
Publicado: (2021)

Problems with Facial Mimicry Might Contribute to Emotion Recognition Impairment in Parkinson's Disease
por: Prenger, Margaret T. M., et al.
Publicado: (2018)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Parkinson’s disease, dopaminergic drugs and the plant world
por: Kempster, Peter, et al.
Publicado: (2022)

Risky decision-making and affective features of impulse control disorders in Parkinson’s disease
por: Martini, Alice, et al.
Publicado: (2017)

Editorial: Impulse Control Disorders, Impulsivity and Related Behaviors in Parkinson's Disease
por: Rodríguez-Violante, Mayela, et al.
Publicado: (2019)

Social Symptoms of Parkinson's Disease
por: Prenger, Margaret T. M., et al.
Publicado: (2020)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Author Correction: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
por: Lee, Myung Jun, et al.
Publicado: (2022)

Impulse control disorders in Parkinson's disease
por: Stacy, Mark
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9tvqmo5keg7cesnuhtu9n1b3bi